| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 45,442 shares worth roughly $3.7M.
Counted by filing, the last 12 months brought no open-market purchases and 23 sales by 5 insiders worth about $12.4M. The 12 months before that brought no open-market purchases and 17 sales by 5 insiders worth about $10.0M.
19 of the 23 sales in the last 12 months were made under a Rule 10b5-1 trading plan; the rest were not.
No insider has bought PCVX shares in the open market in the last two years. The last purchase on record was by Kurt Von Emster on June 16, 2020.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $26.14M | - | |
| COO | 145.4K | $8.84M | - | |
| CFO | 95.3K | $5.80M | - | |
| Other | 68.1K | $4.14M | - | |
| Other | 52.6K | $3.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Jim Wassil53 | EVP, Chief Scientific Ofc, COO | Sale+OE10b5-1 | 18,000 | $86.74 | $1,561,320.00 | -11.0% | - | - | |
| Oct 5, 2026 | Elvia Cowan71 | SVP, Finance & CAO | Sale+OE10b5-1 | 19,000 | $86.74 | $1,648,060.00 | -40.5% | - | - | |
| Oct 1, 2026 | Jim Wassil53 | EVP, Chief Scientific Ofc, COO | Sale+OE10b5-1 | 2,250 | $56.67 | $127,513.30 | -1.5% | - | - | |
| Sep 9, 2026 | Jim Wassil53 | EVP, Chief Scientific Ofc, COO | Sell | 2,715 | $60.35 | $163,862.97 | -1.8% | - | - | |
| Sep 1, 2026 | Jim Wassil53 | Chief Operating Officer | Sale+OE | 3,477 | $61.07 | $212,351.63 | -2.2% | - | - | |
| Aug 5, 2026 | Harpreet S. Dhaliwal | Chief Technical Ops Officer | Sale+OE10b5-1 | 17,000 | $55.00 | $935,068.00 | -18.1% | +12.0% | - | |
| Aug 3, 2026 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 10,000 | $53.89 | $538,879.35 | -8.7% | - | - | |
| Aug 3, 2026 | Jim Wassil53 | Chief Operating Officer | Sale+OE10b5-1 | 2,250 | $53.86 | $121,194.84 | -1.4% | - | - | |
| Jul 27, 2026 | Grant Pickering50 | Chief Executive Officer | Sale+OE10b5-1 | 18,198 | $55.63 | $1,012,375.29 | -12.0% | +8.9% | - | |
| Jul 6, 2026 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 10,000 | $57.28 | $572,836.81 | -8.7% | +29.6% | - |